Authors: Skog, ALH Ragnhammar, P Fagerberg, J Frodin, JE Goldinger, M Koldestam, H Liljefors, M Nilsson, B Shetye, J Wersall, P Mellstedt, H

Citation: Alh. Skog et al., Clinical effects of monoclonal antibody 17-1A combined with granulocyte/macrophage-colony-stimulating factor and interleukin-2 for treatment of patients with advanced colorectal carcinoma, CANCER IMMU, 48(8), 1999, pp. 463-470